Pricing Log in Create free account
Friday 6 November 2026 Export GKOS’s income statement to Excel — free account

Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.

Revenue
+58.0%
EPS
+110.7%
Free cash flow
+411.2%
Total debt
−2.25%

Quarter to September 2026, against a year earlier

225.48 5.50 +2.50%
Market cap
$13.0B
P/E
0.0×
Fwd P/E
−803×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Glaukos Corporation (GKOS) EV/EBITDA

Alert me on EV/EBITDA

Glaukos Corporation has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 819× (September 2022) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 577× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 253× 128.16%
FY2016 111× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 819×
Ten-year median 0.0×
Current reading's percentile 73

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
GKOS Glaukos Corporation n/m
BIO.B Bio-Rad Laboratories, Inc. compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
GMED Globus Medical, Inc. compare 11.9×
ZBH Zimmer Biomet Holdings, Inc. compare 12.1×
PODD Insulet Corporation compare 16.1×
PEN Penumbra, Inc. compare 57.3×
BRKR Bruker Corporation compare 66.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on GKOS